623 related articles for article (PubMed ID: 27666766)
21. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
22. Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers.
Bob R; Falini B; Marafioti T; Paterson JC; Pileri S; Stein H
Histopathology; 2013 Oct; 63(4):482-98. PubMed ID: 23855758
[TBL] [Abstract][Full Text] [Related]
23. Marginal zone B-Cell lymphoma among primary B-Cell lymphoma of Waldeyer's ring: histopathologic and immunohistochemical study of 16 tonsillectomy specimens.
Kojima M; Nakamura N; Shimizu K; Tamaki Y; Itoh H; Nakamura S
Int J Surg Pathol; 2008 Apr; 16(2):164-70. PubMed ID: 18417673
[TBL] [Abstract][Full Text] [Related]
24. The Distinctive Nature of Thyroid MALT Lymphomas Including IRTA1 Expression.
Carlsen ED; Davis AR; Cook JR; Swerdlow SH
Am J Surg Pathol; 2023 Mar; 47(3):370-378. PubMed ID: 36729757
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathologic features of primary hepatic marginal zone lymphoma of mucosa-associated lymphoid tissue and hepatic pseudolymphoma].
Liu C; Li X; Li H; Gong QX; Li Y; Wang Z; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):39-44. PubMed ID: 29325249
[No Abstract] [Full Text] [Related]
26. Bone marrow involvement by marginal zone B-cell lymphomas of different types.
Inamdar KV; Medeiros LJ; Jorgensen JL; Amin HM; Schlette EJ
Am J Clin Pathol; 2008 May; 129(5):714-22. PubMed ID: 18426730
[TBL] [Abstract][Full Text] [Related]
27. Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches.
Nakamura S; Ponzoni M
Pathology; 2020 Jan; 52(1):15-29. PubMed ID: 31757436
[TBL] [Abstract][Full Text] [Related]
28. Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
Go JH; Yang WI; Ree HJ
Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
[TBL] [Abstract][Full Text] [Related]
31. EBV-positive nodal low-grade B-cell lymphoma with BCL3, IgA and IRTA1 expression: Is this a polymorphic lymphoproliferative disorder or an EBV-positive nodal marginal zone lymphoma?
Fujimoto M; Yamashita Y; Haga H; Akasaka T; Iwahashi Y; Warigaya K; Kojima F; Hama Y; Tamura S; Sonoki T; Murata SI
Pathol Int; 2018 Sep; 68(9):538-540. PubMed ID: 29920862
[No Abstract] [Full Text] [Related]
32. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in understanding the biology of marginal zone lymphoma.
Bertoni F; Rossi D; Zucca E
F1000Res; 2018; 7():406. PubMed ID: 29657712
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry for IRTA1 and MNDA helps differentiate gastric MALT lymphoma from chronic gastritis/reactive lymphocyte hyperplasia.
Ayada Y; Igawa T; Naoi Y; Horikawa K; Tabata T; Tanaka T; Yoshino T
J Clin Exp Hematop; 2022 Dec; 62(4):195-201. PubMed ID: 36436933
[TBL] [Abstract][Full Text] [Related]
35. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
[TBL] [Abstract][Full Text] [Related]
36. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
37. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
Dallenbach FE; Coupland SE; Stein H
Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
[TBL] [Abstract][Full Text] [Related]
38. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
39. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells.
Bu X; Zheng Z; Wang C; Yu Y
Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308
[TBL] [Abstract][Full Text] [Related]
40. Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.
Hatem J; Schrank-Hacker AM; Watt CD; Morrissette JJ; Rubin AI; Kim EJ; Nasta SD; Wasik MA; Bogusz AM
Diagn Pathol; 2016 Dec; 11(1):137. PubMed ID: 27993143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]